Renal Cell Cancer, Recurrent Completed Phase 1 Trials for Levomenthol (DB00825)

Also known as: Recurrent Renal Cell Cancer

IndicationStatusPhase
DBCOND0082537 (Renal Cell Cancer, Recurrent)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00112476Temsirolimus and Bryostatin 1 in Treating Patients With Unresectable or Metastatic Solid TumorsTreatment
NCT01155258Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid TumorsTreatment
NCT01198184Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 and Temsirolimus in Treating Patients With Advanced Solid TumorsTreatment